Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

(Point-injection therapy combining baihui acupuncture with parenteral solution of breviscapine for post-cerebral infarction depression) [Chinese - simplified characters]
Huang D-H, Wang C-Y, Huang J-H, Ye Y, Chen X-H
Zhongguo Linchuang Kangfu [Chinese Journal of Clinical Rehabilitation] 2004 Oct 5;8(28):6132-6133
clinical trial
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

AIM: To study the difference in therapeutic effects and side effects between point-injection therapy combining baihui (Du 20) acupuncture with parenteral solution of breviscapine and amitriptyline in treating post-cerebral infarction depression (PCID). METHODS: A total of 85 patients with PCID were randomly divided into acupuncture and point-injection group (n = 43) and amitripty group (n = 42 to treat and observe for eight weeks, and the results were assessed by Hamilton rating scale for depression (HAMD) before and 2, 4, 8 weeks after treatment, and the side effects were compared at the same time. RESULTS: The effective rate of acupuncture and point-injection group was 86.04%, which was higher than that of the amitriptyline group (67.90%, p < 0.05). CONCLUSION: Point-injection therapy combining baihui (Du 20) acupuncture with parenteral solution of breviscapine has better effects for treating PCID.

Full text (sometimes free) may be available at these link(s):      help